Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1968 Jul;96(1):131–138. doi: 10.1128/jb.96.1.131-138.1968

Dynamics in Development of Experimental Streptococcal Immunity in Mice

J Gabriel Michael 1, Benedict F Massell 1
PMCID: PMC252263  PMID: 5663565

Abstract

The interrelation between the humoral and cellular factors in the development of immunity to experimental streptococcal infection was investigated. Early resistance to infection was caused by stimulating the phagocytic cells to function efficiently in the absence of opsonins. Subsequently, the appearance of cytophilic antibodies provided further means for elimination of streptococci. Thus, in the early stages of specific antistreptococcal immunity, resistance was observed in the absence of circulating anti-M antibodies. The type-specific antibodies that appeared in the later stage did not seem to improve clearance of streptococci in the splanchnic tissues. After an intravenous lethal challenge of mice with virulent streptococci, these antibodies did not provide increased protection. The circulating anti-M antibodies were shown to play a beneficial, indeed, a crucial, role when the infection occurred in a region in which the phagocytic cells were present in a rather limited number.

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYDEN S. V., SORKIN E. The adsorption of antigen by spleen cells previously treated with antiserum in vitro. Immunology. 1960 Jul;3:272–283. [PMC free article] [PubMed] [Google Scholar]
  2. FLECK D. G. Mouse protection and enhancement of phagocytosis by antisera to Streptococcus pyogenes. Br J Exp Pathol. 1956 Aug;37(4):406–414. [PMC free article] [PubMed] [Google Scholar]
  3. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  4. LANCEFIELD R. C., PERLMANN G. E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med. 1952 Jul;96(1):71–82. doi: 10.1084/jem.96.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LANCEFIELD R. C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959 Aug 1;110(2):271–292. doi: 10.1084/jem.110.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MICHAEL J. G., WHITBY J. L., LANDY M. Increase in specific bactericidal antibodies after administration of endotoxin. Nature. 1961 Jul 15;191:296–297. doi: 10.1038/191296a0. [DOI] [PubMed] [Google Scholar]
  7. Nelson D. S., Boyden S. V. Macrophage cytophilic antibodies and delayed hypersensitivity. Br Med Bull. 1967 Jan;23(1):15–20. doi: 10.1093/oxfordjournals.bmb.a070508. [DOI] [PubMed] [Google Scholar]
  8. ROWLEY D. Rapidly induced changes in the level of non-specific immunity in laboratory animals. Br J Exp Pathol. 1956 Jun;37(3):223–234. [PMC free article] [PubMed] [Google Scholar]
  9. ROWLEY D., TURNER K. J., JENKIN C. R. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 3. CELL-BOUND ANTIBODY. Aust J Exp Biol Med Sci. 1964 Apr;42:237–248. doi: 10.1038/icb.1964.25. [DOI] [PubMed] [Google Scholar]
  10. Rotta J., Prendergast T. J., Karakawa W. W., Harmon C. K., Krause R. M. Enhanced resistance to streptococcal infection induced in mice by cell wall mucopeptide. J Exp Med. 1965 Nov 1;122(5):877–890. doi: 10.1084/jem.122.5.877. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES